Ignite Creation Date:
2025-12-24 @ 6:30 PM
Ignite Modification Date:
2026-02-23 @ 8:08 PM
Study NCT ID:
NCT05920668
Status:
UNKNOWN
Last Update Posted:
2023-06-27
First Post:
2023-06-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Observational Study of Orelabrutinib in the Treatment of Chronic Lymphocytic Leukemia/Small Cell Lymphoma
Sponsor:
Wang Xin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-05
First Submit QC Date:
None
Study First Post Date:
2023-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-16
Last Update Post Date:
2023-06-27
Last Update Post Date Type:
ACTUAL